Need help finding what you are looking for?
Contact Us
PUBLISHER: Persistence Market Research | PRODUCT CODE: 1470730
PUBLISHER: Persistence Market Research | PRODUCT CODE: 1470730
Overweight Treatment Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
PUBLISHED:
PAGES: 245 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Persistence Market Research presents a comprehensive analysis of the global overweight treatment market, providing insights into its growth drivers, challenges, and emerging trends. This detailed report offers exclusive data and statistics projecting the market's trajectory from 2024 to 2031.
Key Insights:
- Market Size (2024E): US$41.2 Billion
- Projected Market Value (2031F): US$74.1 Billion
- Global Market Growth Rate (CAGR 2024 to 2031): 7.8%
Overweight Treatment Market - Report Scope:
The overweight treatment market addresses the growing concern of obesity and overweight conditions worldwide, offering various therapeutic interventions, lifestyle modifications, and surgical procedures to manage weight and improve overall health. With the rise in sedentary lifestyles, unhealthy dietary habits, and metabolic disorders, obesity has become a global epidemic, driving demand for effective treatment solutions. The market encompasses pharmaceuticals, medical devices, surgical procedures, and lifestyle interventions aimed at weight management and obesity prevention.
Market Growth Drivers:
The increasing prevalence of obesity and overweight conditions, coupled with rising awareness about the health risks associated with excess weight, drives the demand for overweight treatment solutions globally. Lifestyle factors such as poor diet, lack of physical activity, and stress contribute to the obesity epidemic, creating a growing market for weight management therapies and interventions. Additionally, government initiatives, public health campaigns, and reimbursement policies aimed at obesity prevention and treatment further stimulate market growth.
Market Restraints:
Despite the growing awareness and demand for overweight treatment solutions, several challenges hinder market growth. These include limited access to healthcare services in underserved regions, socioeconomic disparities in obesity prevalence, and cultural barriers to adopting healthy lifestyles. Moreover, the stigma associated with obesity and the perception of weight management as a cosmetic issue rather than a medical concern pose challenges for healthcare providers and policymakers in addressing the obesity epidemic effectively.
Market Opportunities:
The evolving landscape of overweight treatment presents opportunities for innovation and collaboration across various sectors, including healthcare, pharmaceuticals, nutrition, and fitness. With advancements in medical technology, there is a growing focus on personalized approaches to weight management, incorporating genetic, metabolic, and behavioral factors into treatment strategies. Furthermore, the integration of digital health solutions, wearable devices, and telemedicine platforms enhances accessibility and engagement in obesity management programs, creating new opportunities for market expansion.
Key Questions Answered in the Report:
- What are the primary factors driving the growth of the overweight treatment market?
- How are technological advancements shaping the landscape of obesity management and weight loss interventions?
- What are the key challenges hindering market growth, and how can they be addressed?
- Which regions are expected to witness significant growth in the overweight treatment market?
- Who are the key stakeholders in the market, and what strategies are they adopting to address the obesity epidemic?
Competitive Intelligence and Business Strategy:
Leading players in the overweight treatment market focus on innovation, research, and strategic partnerships to address the complex challenges of obesity management. Pharmaceutical companies invest in the development of novel therapeutics targeting obesity-related metabolic disorders, while medical device manufacturers introduce advanced devices for minimally invasive weight loss procedures. Moreover, healthcare providers collaborate with wellness organizations, nutritionists, and fitness professionals to offer comprehensive weight management programs tailored to individual needs.
Key Companies Profiled:
- Novo Nordisk A/S
- Roche Holding AG
- GlaxoSmithKline plc
- Medtronic plc
- Johnson & Johnson Services, Inc.
- Allergan plc
- Abbott Laboratories
- Pfizer Inc.
- Amgen Inc.
- Merck & Co., Inc.
Overweight Treatment Market Research Segmentation:
Overweight Treatment Market by Treatment:
- Drug Treatment
- Bupropion and Naltrexone
- Orlistat
- Phentermine and Topiramate
- Liraglutide
- Others
- Supplements
- Medical Devices / Implants
- Gastric Balloons
- Gastric Bands
- Stapling Devices
Overweight Treatment Market by Distribution Channel:
- Institutional Sales
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Retail Sales
- Retail Pharmacy
- Drug Stores
- Supermarkets / Hypermarkets
- Health & Beauty Stores
- Online Sales
Overweight Treatment Market by Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Product Code: PMRREP33086
Table of Contents
1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Demand Side Trends
- 1.3. Supply Side Trends
- 1.4. Technology Roadmap
- 1.5. Analysis and Recommendations
2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 2.3. Inclusions and Exclusions
3. Key Market Trends
- 3.1. Key Trends Impacting the Market
- 3.2. Innovation / Development Trends
4. Key Success Factors
- 4.1. Product Adoption Analysis
- 4.2. Obesity Rate by Country
- 4.3. Obesity Drugs Pipeline Analysis
- 4.4. Obesity Drug Withdrawal Analysis
- 4.5. Obesity Drug / Device Withdrawal, Termination from Clinical Trials
- 4.6. Regulatory Scenario
- 4.7. Key Promotional Strategies by Manufacturers
- 4.8. Porter's Analysis
- 4.9. PESTEL Analysis
5. COVID19 Crisis Analysis
- 5.1. Current COVID19 Statistics and Probable Future Impact
- 5.2. Current GDP Projection and Probable Impact
- 5.3. Current Economic Projection as compared to 2008 Economic analysis
- 5.4. COVID-19 and Impact Analysis
- 5.4.1. Revenue by Treatment
- 5.4.2. Revenue by Distribution Channel
- 5.4.3. Revenue by Country
6. Market Background
- 6.1. Macro-Economic Factors
- 6.1.1. Global GDP Growth Outlook
- 6.1.2. Per-Capita Healthcare Expenditure
- 6.2. Forecast Factors - Relevance & Impact
- 6.2.1. COVID-19 Pandemic
- 6.2.2. Increasing Prevalence of Obesity
- 6.2.3. Rise in R&D Investments
- 6.2.4. Top Overweight Treatment Companies and Their Historical Growth
- 6.2.5. Rise in Number of Clinical Studies
- 6.2.6. Increasing Investment in Obesity Research
- 6.2.7. GDP Growth
- 6.2.8. Adoption Rate of Overweight Treatment Products
- 6.3. Market Dynamics
- 6.3.1. Drivers
- 6.3.2. Restraints
- 6.3.3. Opportunity Analysis
7. Global Overweight Treatment Market Demand (in Value or Size in US$ MN) Analysis 2019-2023 and Forecast, 2024-2031
- 7.1. Historical Market Value (US$ MN) Analysis, 2019-2023
- 7.2. Current and Future Market Value (US$ MN) Projections, 2024-2031
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis
8. Global Overweight Treatment Market Analysis 2019-2023 and Forecast 2024-2031, by Treatment
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size (US$ Mn) Analysis by Treatment, 2019-2023
- 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Treatment, 2024-2031
- 8.3.1. Drug Treatment
- 8.3.1.1. Bupropion and Naltrexone
- 8.3.1.2. Orlistat
- 8.3.1.3. Phentermine and Topiramate
- 8.3.1.4. Liraglutide
- 8.3.1.5. Others
- 8.3.2. Supplements
- 8.3.3. Medical Devices / Implants
- 8.3.3.1. Gastric Balloons
- 8.3.3.2. Gastric Bands
- 8.3.3.3. Stapling Devices
- 8.3.1. Drug Treatment
- 8.4. Market Attractiveness Analysis by Treatment
9. Global Overweight Treatment Market Analysis 2019-2023 and Forecast 2024-2031, by Distribution Channel
- 9.1. Introduction / Key Findings
- 9.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2019-2023
- 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Distribution Channel, 2024-2031
- 9.3.1. Institutional Sales
- 9.3.1.1. Hospitals
- 9.3.1.2. Specialty Clinics
- 9.3.1.3. Ambulatory Surgical Centers
- 9.3.2. Retail Sales
- 9.3.2.1. Retail Pharmacy
- 9.3.2.2. Drug Stores
- 9.3.2.3. Supermarkets/ Hypermarkets
- 9.3.2.4. Health & Beauty Stores
- 9.3.3. Online Sales
- 9.3.1. Institutional Sales
- 9.4. Market Attractiveness Analysis by Distribution Channel
10. Global Overweight Treatment Market Analysis 2019-2023 and Forecast 2024-2031, by Region
- 10.1. Introduction / Key Findings
- 10.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2023
- 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2024-2031
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. East Asia
- 10.3.5. South Asia
- 10.3.6. Oceania
- 10.3.7. Middle East and Africa (MEA)
- 10.4. Market Attractiveness Analysis By Region
11. North America Overweight Treatment Market Analysis 2019-2023 and Forecast 2024-2031
- 11.1. Introduction
- 11.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
- 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2031
- 11.3.1. By Country
- 11.3.1.1. U.S.
- 11.3.1.2. Canada
- 11.3.2. By Treatment
- 11.3.3. By Distribution Channel
- 11.3.1. By Country
- 11.4. Market Attractiveness Analysis
- 11.4.1. By Country
- 11.4.2. By Treatment
- 11.4.3. By Distribution Channel
- 11.5. Market Trends
- 11.6. Key Market Participants - Intensity Mapping
- 11.7. Drivers and Restraints - Impact Analysis
- 11.8. Country Level Analysis & Forecast
- 11.8.1. U.S. Overweight Treatment Market Analysis
- 11.8.1.1. Introduction
- 11.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 11.8.1.2.1. By Treatment
- 11.8.1.2.2. By Distribution Channel
- 11.8.2. Canada Overweight Treatment Market Analysis
- 11.8.2.1. Introduction
- 11.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 11.8.2.2.1. By Treatment
- 11.8.2.2.2. By Distribution Channel
- 11.8.1. U.S. Overweight Treatment Market Analysis
12. Latin America Overweight Treatment Market Analysis 2019-2023 and Forecast 2024-2031
- 12.1. Introduction
- 12.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
- 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2031
- 12.3.1. By Country
- 12.3.1.1. Mexico
- 12.3.1.2. Brazil
- 12.3.1.3. Argentina
- 12.3.1.4. Rest of Latin America
- 12.3.1.4.1. By Treatment
- 12.3.1.4.2. By Distribution Channel
- 12.3.1. By Country
- 12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Treatment
- 12.4.3. By Distribution Channel
- 12.5. Market Trends
- 12.6. Key Market Participants - Intensity Mapping
- 12.7. Drivers and Restraints - Impact Analysis
- 12.8. Country Level Analysis & Forecast
- 12.8.1. Mexico Overweight Treatment Market Analysis
- 12.8.1.1. Introduction
- 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 12.8.1.2.1. By Treatment
- 12.8.1.2.2. By Distribution Channel
- 12.8.2. Brazil Overweight Treatment Market Analysis
- 12.8.2.1. Introduction
- 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 12.8.2.2.1. By Treatment
- 12.8.2.2.2. By Distribution Channel
- 12.8.3. Argentina Overweight Treatment Market Analysis
- 12.8.3.1. Introduction
- 12.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 12.8.3.2.1. By Treatment
- 12.8.3.2.2. By Distribution Channel
- 12.8.1. Mexico Overweight Treatment Market Analysis
13. Europe Overweight Treatment Market Analysis 2019-2023 and Forecast 2024-2031
- 13.1. Introduction
- 13.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
- 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2031
- 13.3.1. By Country
- 13.3.1.1. Germany
- 13.3.1.2. Italy
- 13.3.1.3. France
- 13.3.1.4. U.K.
- 13.3.1.5. Spain
- 13.3.1.6. BENELUX
- 13.3.1.7. Nordic Countries & Russia
- 13.3.1.8. Rest of Europe
- 13.3.2. By Treatment
- 13.3.3. By Distribution Channel
- 13.3.1. By Country
- 13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Treatment
- 13.4.3. By Distribution Channel
- 13.5. Market Trends
- 13.6. Key Market Participants - Intensity Mapping
- 13.7. Drivers and Restraints - Impact Analysis
- 13.8. Country Level Analysis & Forecast
- 13.8.1. Germany Overweight Treatment Market Analysis
- 13.8.1.1. Introduction
- 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.1.2.1. By Treatment
- 13.8.1.2.2. By Distribution Channel
- 13.8.2. Italy Overweight Treatment Market Analysis
- 13.8.2.1. Introduction
- 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.2.2.1. By Treatment
- 13.8.2.2.2. By Distribution Channel
- 13.8.3. France Overweight Treatment Market Analysis
- 13.8.3.1. Introduction
- 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.3.2.1. By Treatment
- 13.8.3.2.2. By Distribution Channel
- 13.8.4. U.K. Overweight Treatment Market Analysis
- 13.8.4.1. Introduction
- 13.8.4.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.4.2.1. By Treatment
- 13.8.4.2.2. By Distribution Channel
- 13.8.5. Spain Overweight Treatment Market Analysis
- 13.8.5.1. Introduction
- 13.8.5.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.5.2.1. By Treatment
- 13.8.5.2.2. By Distribution Channel
- 13.8.6. BENELUX Overweight Treatment Market Analysis
- 13.8.6.1. Introduction
- 13.8.6.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.6.2.1. By Treatment
- 13.8.6.2.2. By Distribution Channel
- 13.8.7. Nordic Countries & Russia Overweight Treatment Market Analysis
- 13.8.7.1. Introduction
- 13.8.7.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.7.2.1. By Treatment
- 13.8.7.2.2. By Distribution Channel
- 13.8.1. Germany Overweight Treatment Market Analysis
14. East Asia Overweight Treatment Market Analysis 2019-2023 and Forecast 2024-2031
- 14.1. Introduction
- 14.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
- 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2031
- 14.3.1. By Country
- 14.3.1.1. China
- 14.3.1.2. Japan
- 14.3.1.3. South Korea
- 14.3.1.3.1. By Treatment
- 14.3.1.3.2. By Distribution Channel
- 14.3.1. By Country
- 14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Treatment
- 14.4.3. By Distribution Channel
- 14.5. Market Trends
- 14.6. Key Market Participants - Intensity Mapping
- 14.7. Drivers and Restraints - Impact Analysis
- 14.8. Country Level Analysis & Forecast
- 14.8.1. China Overweight Treatment Market Analysis
- 14.8.1.1. Introduction
- 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.1.2.1. By Treatment
- 14.8.1.2.2. By Distribution Channel
- 14.8.2. Japan Overweight Treatment Market Analysis
- 14.8.2.1. Introduction
- 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.2.2.1. By Treatment
- 14.8.2.2.2. By Distribution Channel
- 14.8.3. South Korea Overweight Treatment Market Analysis
- 14.8.3.1. Introduction
- 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.3.2.1. By Treatment
- 14.8.3.2.2. By Distribution Channel
- 14.8.1. China Overweight Treatment Market Analysis
15. South Asia Overweight Treatment Market Analysis 2019-2023 and Forecast 2024-2031
- 15.1. Introduction
- 15.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
- 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2031
- 15.3.1. By Country
- 15.3.1.1. India
- 15.3.1.2. Indonesia
- 15.3.1.3. Malaysia
- 15.3.1.4. Philippines
- 15.3.1.5. Thailand
- 15.3.1.6. Vietnam
- 15.3.1.7. Rest of South Asia
- 15.3.2. By Treatment
- 15.3.3. By Distribution Channel
- 15.3.1. By Country
- 15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Treatment
- 15.4.3. By Distribution Channel
- 15.5. Market Trends
- 15.6. Key Market Participants - Intensity Mapping
- 15.7. Drivers and Restraints - Impact Analysis
- 15.8. Country Level Analysis & Forecast
- 15.8.1. India Overweight Treatment Market Analysis
- 15.8.1.1. Introduction
- 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.1.2.1. By Treatment
- 15.8.1.2.2. By Distribution Channel
- 15.8.2. Indonesia Overweight Treatment Market Analysis
- 15.8.2.1. Introduction
- 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.2.2.1. By Treatment
- 15.8.2.2.2. By Distribution Channel
- 15.8.3. Malaysia Overweight Treatment Market Analysis
- 15.8.3.1. Introduction
- 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.3.2.1. By Treatment
- 15.8.3.2.2. By Distribution Channel
- 15.8.4. Philippines Overweight Treatment Market Analysis
- 15.8.4.1. Introduction
- 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.4.2.1. By Treatment
- 15.8.4.2.2. By Distribution Channel
- 15.8.5. Thailand Overweight Treatment Market Analysis
- 15.8.5.1. Introduction
- 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.5.2.1. By Treatment
- 15.8.5.2.2. By Distribution Channel
- 15.8.6. Vietnam Overweight Treatment Market Analysis
- 15.8.6.1. Introduction
- 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.6.2.1. By Treatment
- 15.8.6.2.2. By Distribution Channel
- 15.8.1. India Overweight Treatment Market Analysis
16. Oceania Overweight Treatment Market 2019-2023 and Forecast 2024-2031
- 16.1. Introduction
- 16.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
- 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2031
- 16.3.1. By Country
- 16.3.1.1. Australia
- 16.3.1.2. New Zealand
- 16.3.2. By Treatment
- 16.3.3. By Distribution Channel
- 16.3.1. By Country
- 16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Treatment
- 16.4.3. By Distribution Channel
- 16.5. Market Trends
- 16.6. Key Market Participants - Intensity Mapping
- 16.7. Drivers and Restraints - Impact Analysis
- 16.8. Country Level Analysis & Forecast
- 16.8.1. Australia Overweight Treatment Market Analysis
- 16.8.1.1. Introduction
- 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.1.2.1. By Treatment
- 16.8.1.2.2. By Distribution Channel
- 16.8.2. New Zealand Overweight Treatment Market Analysis
- 16.8.2.1. Introduction
- 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.2.2.1. By Treatment
- 16.8.2.2.2. By Distribution Channel
- 16.8.1. Australia Overweight Treatment Market Analysis
17. Middle East and Africa (MEA) Overweight Treatment Market Analysis 2019-2023 and Forecast 2024-2031
- 17.1. Introduction
- 17.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2019-2023
- 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2031
- 17.3.1. By Country
- 17.3.1.1. GCC Countries
- 17.3.1.2. Israel
- 17.3.1.3. Turkey
- 17.3.1.4. South Africa & North Africa
- 17.3.1.5. Rest of Middle East and Africa
- 17.3.2. By Treatment
- 17.3.3. By Distribution Channel
- 17.3.1. By Country
- 17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Treatment
- 17.4.3. By Distribution Channel
- 17.5. Market Trends
- 17.6. Key Market Participants - Intensity Mapping
- 17.7. Drivers and Restraints - Impact Analysis
- 17.8. Country Level Analysis & Forecast
- 17.8.1. GCC Countries Overweight Treatment Market Analysis
- 17.8.1.1. Introduction
- 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.1.2.1. By Treatment
- 17.8.1.2.2. By Distribution Channel
- 17.8.2. Israel Overweight Treatment Market Analysis
- 17.8.2.1. Introduction
- 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.2.2.1. By Treatment
- 17.8.2.2.2. By Distribution Channel
- 17.8.3. Turkey Overweight Treatment Market Analysis
- 17.8.3.1. Introduction
- 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.3.2.1. By Treatment
- 17.8.3.2.2. By Distribution Channel
- 17.8.4. South Africa & North Africa Overweight Treatment Market Analysis
- 17.8.4.1. Introduction
- 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.4.2.1. By Treatment
- 17.8.4.2.2. By Distribution Channel
- 17.8.1. GCC Countries Overweight Treatment Market Analysis
18. Market Structure Analysis
- 18.1. Market Analysis by Tier of Companies
- 18.2. Market Share Analysis of Top Players
- 18.3. Market Presence Analysis
- 18.3.1. Regional footprint of Players
- 18.3.2. Channel Foot Print by Players
19. Competition Analysis
- 19.1. Competition Dashboard
- 19.2. Competition Benchmarking
- 19.3. Competition Deep Dive
- 19.3.1. Novo Nordisk A/S
- 19.3.1.1. Overview
- 19.3.1.2. Product Portfolio
- 19.3.1.3. Key Financials by Market Segments (Product/Channel/Region)
- 19.3.1.4. Sales Footprint
- 19.3.1.5. Strategy Overview
- 19.3.1.6. SWOT Analysis
- 19.3.2. VIVUS LLC
- 19.3.2.1. Overview
- 19.3.2.2. Product Portfolio
- 19.3.2.3. Key Financials by Market Segments (Product/Channel/Region)
- 19.3.2.4. Sales Footprint
- 19.3.2.5. Strategy Overview
- 19.3.2.6. SWOT Analysis
- 19.3.3. AstraZeneca
- 19.3.3.1. Overview
- 19.3.3.2. Product Portfolio
- 19.3.3.3. Key Financials by Market Segments (Product/Channel/Region)
- 19.3.3.4. Sales Footprint
- 19.3.3.5. Strategy Overview
- 19.3.3.6. SWOT Analysis
- 19.3.4. Currax Pharmaceuticals LLC.
- 19.3.4.1. Overview
- 19.3.4.2. Product Portfolio
- 19.3.4.3. Key Financials by Market Segments (Product/Channel/Region)
- 19.3.4.4. Sales Footprint
- 19.3.4.5. Strategy Overview
- 19.3.4.6. SWOT Analysis
- 19.3.5. Spansules Pharmatech Pvt Ltd
- 19.3.5.1. Overview
- 19.3.5.2. Product Portfolio
- 19.3.5.3. Key Financials by Market Segments (Product/Channel/Region)
- 19.3.5.4. Sales Footprint
- 19.3.5.5. Strategy Overview
- 19.3.5.6. SWOT Analysis
- 19.3.6. Atkins Nutritional Inc.
- 19.3.6.1. Overview
- 19.3.6.2. Product Portfolio
- 19.3.6.3. Key Financials by Market Segments (Product/Channel/Region)
- 19.3.6.4. Sales Footprint
- 19.3.6.5. Strategy Overview
- 19.3.6.6. SWOT Analysis
- 19.3.7. Apollo Endosurgery, Inc.
- 19.3.7.1. Overview
- 19.3.7.2. Product Portfolio
- 19.3.7.3. Key Financials by Market Segments (Product/Channel/Region)
- 19.3.7.4. Sales Footprint
- 19.3.7.5. Strategy Overview
- 19.3.7.6. SWOT Analysis
- 19.3.8. Herbalife Nutrition Ltd.
- 19.3.8.1. Overview
- 19.3.8.2. Product Portfolio
- 19.3.8.3. Key Financials by Market Segments (Product/Channel/Region)
- 19.3.8.4. Sales Footprint
- 19.3.8.5. Strategy Overview
- 19.3.8.6. SWOT Analysis
- 19.3.9. SMP Nutra
- 19.3.9.1. Overview
- 19.3.9.2. Product Portfolio
- 19.3.9.3. Key Financials by Market Segments (Product/Channel/Region)
- 19.3.9.4. Sales Footprint
- 19.3.9.5. Strategy Overview
- 19.3.9.6. SWOT Analysis
- 19.3.10. Allurion Technologies
- 19.3.10.1. Overview
- 19.3.10.2. Product Portfolio
- 19.3.10.3. Key Financials by Market Segments (Product/Channel/Region)
- 19.3.10.4. Sales Footprint
- 19.3.10.5. Strategy Overview
- 19.3.10.6. SWOT Analysis
- 19.3.11. ReShape Lifesciences, Inc.
- 19.3.11.1. Overview
- 19.3.11.2. Product Portfolio
- 19.3.11.3. Key Financials by Market Segments (Product/Channel/Region)
- 19.3.11.4. Sales Footprint
- 19.3.11.5. Strategy Overview
- 19.3.11.6. SWOT Analysis
- 19.3.12. Bariatric Solutions GmbH
- 19.3.12.1. Overview
- 19.3.12.2. Product Portfolio
- 19.3.12.3. Key Financials by Market Segments (Product/Channel/Region)
- 19.3.12.4. Sales Footprint
- 19.3.12.5. Strategy Overview
- 19.3.12.6. SWOT Analysis
- 19.3.13. Silimed
- 19.3.13.1. Overview
- 19.3.13.2. Product Portfolio
- 19.3.13.3. Key Financials by Market Segments (Product/Channel/Region)
- 19.3.13.4. Sales Footprint
- 19.3.13.5. Strategy Overview
- 19.3.13.6. SWOT Analysis
- 19.3.14. ENDALIS
- 19.3.14.1. Overview
- 19.3.14.2. Product Portfolio
- 19.3.14.3. Key Financials by Market Segments (Product/Channel/Region)
- 19.3.14.4. Sales Footprint
- 19.3.14.5. Strategy Overview
- 19.3.14.6. SWOT Analysis
- 19.3.15. Districlass Medical
- 19.3.15.1. Overview
- 19.3.15.2. Product Portfolio
- 19.3.15.3. Key Financials by Market Segments (Product/Channel/Region)
- 19.3.15.4. Sales Footprint
- 19.3.15.5. Strategy Overview
- 19.3.15.6. SWOT Analysis
- 19.3.16. Medtronic
- 19.3.16.1. Overview
- 19.3.16.2. Product Portfolio
- 19.3.16.3. Key Financials by Market Segments (Product/Channel/Region)
- 19.3.16.4. Sales Footprint
- 19.3.16.5. Strategy Overview
- 19.3.16.6. SWOT Analysis
- 19.3.1. Novo Nordisk A/S
20. Assumptions and Acronyms Used
21. Research Methodology
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.